Chromium Supplementation Shortens QTc Interval Duration In Patients With Type 2 Diabetes Mellitus
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 50 |
| Sex | Both Genders |
| Body Types | Obese, Overweight |
Supplementation of 1,000mcg chromium daily for three months in type II diabetics was able to shorten QTc intervals, suggesting a cardioprotective effect (as prolonged QTc intervals are indicative of cardiovascular mortality). Aside from insulin (which was also reduced), no other parameter was influenced.
